Literature DB >> 1890710

Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease.

M Corral-Debrinski1, G Stepien, J M Shoffner, M T Lott, K Kanter, D C Wallace.   

Abstract

OBJECTIVE: --Oxidative phosphorylation (OXPHOS) deficiency due to hypoxemia or other causes was hypothesized to increase oxygen radical generation, damage mitochondrial DNA (mtDNA), and reduce adenosine triphosphate synthesis, resulting in compensatory OXPHOS gene induction. Therefore, we investigated the levels of mtDNA damage and OXPHOS transcripts in normal and ischemic hearts, and then in other forms of heart disease.
DESIGN: --DNA was extracted from the heart and the levels of the common 4977 base pair mtDNA deletion were quantitated as an index for mtDNA damage. Total RNA was extracted from hearts and analyzed for OXPHOS transcript levels.
RESULTS: --In control hearts, the 4977 base pair mtDNA deletion appeared at age 40 years and reached a maximum deletion of 0.0035%. Much higher levels were found in ischemic hearts (0.02% to 0.85%), as well as in three of 10 cases with other types of heart disease (0.017% to 0.16%). The OXPHOS transcripts were increased in all diseased hearts.
CONCLUSION: --Ischemic hearts have increased mtDNA damage and OXPHOS gene expression, suggesting that mtDNA damage is associated with OXPHOS deficiency. Oxidative phosphorylation defects may also play a role in some other forms of cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1890710

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  66 in total

1.  Muscle carnitine acetyltransferase and carnitine deficiency in a case of mitochondrial encephalomyopathy.

Authors:  B Melegh; L Seress; T Bedekovics; G Kispál; B Sümegi; K Trombitás; K Méhes
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

2.  The age-related accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method.

Authors:  D G Murdock; N C Christacos; D C Wallace
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  Impaired redox status and cytochrome c oxidase deficiency in patients with polymyalgia rheumatica.

Authors:  P Chariot; X Chevalier; M Yerroum; I Drogou; F J Authier; R Gherardi
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

4.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

Review 5.  Heart mitochondria signaling pathways: appraisal of an emerging field.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

Review 6.  Diseases resulting from mitochondrial DNA point mutations.

Authors:  D C Wallace; M T Lott; J M Shoffner; M D Brown
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

7.  Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology.

Authors:  Mohammed I Alhatou; John T Sladky; Omar Bagasra; Jonathan D Glass
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

Review 8.  Ultrastructural definition of apoptosis in heart failure.

Authors:  Eloisa Arbustini; Agnese Brega; Jagat Narula
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

Review 9.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

10.  MELAS syndrome with mitochondrial tRNA(Leu(UUR)) gene mutation in a Chinese family.

Authors:  C C Huang; R S Chen; C M Chen; H S Wang; C C Lee; C Y Pang; H S Hsu; H C Lee; Y H Wei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.